Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemia

Acute myeloid leukemia (AML) remains a significant health problem, with poor outcomes despite chemotherapy and bone marrow transplants. Although one form of AML, acute promyelocytic leukemia (APL), is successfully treated with all-trans retinoic acid (ATRA), this drug is seemingly ineffective agains...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int Immunol
Autores principales: Buteyn, Nathaniel J, Fatehchand, Kavin, Santhanam, Ramasamy, Fang, Huiqing, Dettorre, Gino M, Gautam, Shalini, Harrington, Bonnie K, Henderson, Sally E, Merchand-Reyes, Giovanna, Mo, Xiaokui, Benson, Don M, Carson, William E, Vasu, Sumithira, Byrd, John C, Butchar, Jonathan P, Tridandapani, Susheela
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Featured Article of the Month
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059202/
https://ncbi.nlm.nih.gov/pubmed/29868798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/intimm/dxy040
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares